Back to today’s briefing

Story perspectives

Sun Pharma Buys Organon for $11.75 B, Biggest Indian Overseas Deal

4/27/2026

38 3 Full Breakdown

Summary

Story summary

Sun Pharmaceutical Industries announced an all-cash $11.75 billion acquisition of Organon & Co, the biggest overseas deal by an Indian pharma firm.
Sun will fund the purchase with cash and bank loans while Organon carries $8.6 billion net debt.
The deal adds more than 70 women’s-health and general medicines sold in roughly 140 countries.
Analysts say it opens China and Brazil but will not markedly change Sun’s U.S. market share.

1 of 1

Story summary

Sun Pharmaceutical Industries announced an all-cash $11.75 billion acquisition of Organon & Co, the biggest overseas deal by an Indian pharma firm.
Sun will fund the purchase with cash and bank loans while Organon carries $8.6 billion net debt.
The deal adds more than 70 women’s-health and general medicines sold in roughly 140 countries.
Analysts say it opens China and Brazil but will not markedly change Sun’s U.S. market share.